Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1922762Erstellt: 25. Oktober 2026

Sodium triacetoxyborohydride → 4-(5-Chloro-2-((4-(oxetan-3-yl)piperidin-1-yl)methyl)thiazolo[5,4-d]pyrimidin-7-yl)morpholine

https://huagongshe.com/reaction/1922762

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktSodium triacetoxyborohydrideHCID 5049666—
Edukt4-(Oxetan-3-yl)piperidineHCID 55264245—
Edukt5-Chloro-7-morpholinothiazolo[5,4-d]pyrimidine-2-carbaldehydeHCID 57685405—
Lösungsmittel1,2-DichloroethaneHCID 11—
Produkt4-(5-Chloro-2-((4-(oxetan-3-yl)piperidin-1-yl)methyl)thiazolo[5,4-d]pyrimidin-7-yl)morpholineHCID 5960570041%

Reaktionsschritte

A solution of 5 -chloro-7-morpholin-4-ylthiazolo [5,4-d]pyrimidine-2-carbaldehyde (1.0 g, 3.52 mmol), 4-oxetan-3-ylpiperidine (536 mg, 4.23 mmol) and molecular sieves (4 Å, powdered, 6.56 g) in DCE (30 mL) was stirred at ambient temperature for 4 h. Sodium triacetoxyborohydride (1.49 g, 7.05 mmol) was added and the mixture stirred for 6 h, then filtered through a pad of Celite® and the filtrate was concentrated in vacuo. The resultant residue was purified by flash chromatography (Si—PPC, DCM:MeOH; gradient from 100:0 to 97:3) to afford the title compound as a cream solid (334 mg, 41%). LCMS (Method A): RT=2.48 min, M+H+=410

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08173650B2
Quelldatensatzuspto-grants-2012_05
ORD IDord-e26ac85ebc0a4506b5614b76c3517a61
Quellennotizuspto-grants-2012_05